Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Recruiting · NCT06863480 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Recruiting | Phase 1 | 2026-09-23 | NCT06863480 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Florida | 315 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Florida Health (UF Health) | Gainesville | United States | 1 |